Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Testosterone reduces heart damage and inflammation after injury.

Gene variation affects prostate issues and hair loss.

CEC levels may be a useful marker for predicting prostate cancer progression.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.